My Breakdown of New Study Showing Vaccines PREVENT post-Covid Heart and Clotting Events

 The study has a series of what I consider flaws plus the raw data they drew conclusions from is hidden from those who might be able to check the conclusions reached in the study. Here is my breakdown of the available data.

Direct Support

Patreon https://www.patreon.com/americaneveryman
Cash App $scotty6199
Zelle rscdesigns@tampabay.rr.com (Chase bank)

FOLLOW/CONTACT:

Twitch: https://www.twitch.tv/beautender

YouTube https://www.youtube.com/c/scottcreighton1

Substack: https://scottcreighton.substack.com/

website: https://nomadiceveryman.blogspot.com/
BitChute: https://www.bitchute.com

(I had to publish this so I can access images from one computer to the next. Will add video in an hour or so but you can check out the data below the fold) 

1. start date of test (image)

2. definition of type of study

3. selection of study participants

4. data not available for review

The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications

'

Introduction

COVID-19 vaccines were approved under emergency authorisation in December 2020 and showed high effectiveness against SARS-CoV-2 infection, COVID-19-related hospitalisation and death.1 2 However, concerns were raised after spontaneous reports of unusual thromboembolic events following adenovirus-based COVID-19 vaccines, an association that was further assessed in observational studies.3 4 More recently, mRNA-based vaccines were found to be associated with a risk of rare myocarditis events.5...

 Evidence is still scarce as to whether the combined effects of COVID-19 vaccines protecting against SARS-CoV-2 infection and reducing post-COVID-19 cardiac and thromboembolic outcomes, outweigh any risks of these complications potentially associated with vaccination....

1. 

 

2. 'We conducted a staggered cohort study based on national vaccination campaigns using electronic health records from the UK, Spain and Estonia. Vaccine rollout was grouped into four stages with predefined enrolment periods. Each stage included all individuals eligible for vaccination, with no previous SARS-CoV-2 infection or COVID-19 vaccine at the start date. Vaccination status was used as a time-varying exposure.'

---

'What is the difference between a cohort study and a randomized clinical trial?

A prospective cohort study follows a group of participants over a period of time to track the development of an outcome of interest, while a randomized controlled trial tests the effectiveness of a specific intervention on a group of people.'

 

'cohort studies recruit and follow participants who share a common characteristic, such as a particular occupation or demographic similarity. During the period of follow-up, some of the cohort will be exposed to a specific risk factor or characteristic; by measuring outcomes over a period of time, it is then possible to explore the impact of this variable'

---

 'The randomized controlled trial (RCT) is the gold standard for causal inference for individual-level interventions'

'the cluster- or group-randomized trial (GRT) is the gold standard for causal inference.'

'The features that have contributed to the success of small (multiple baseline designs) MBDs in some fields are not likely to translate well to public health research. MBDs can be more powerful than GRTs under some conditions, but those conditions involve assumptions that require careful evaluation in practice.

'Conclusions. MBDs will often serve better as a complement of rather than as an alternative to GRTs.' source NIH

 

 

3. database:  'For the UK, we used data from two primary care databases—namely, Clinical Practice Research Datalink, CPRD Aurum13 and CPRD Gold.14 CPRD Aurum currently covers 13 million people from predominantly English practices, while CPRD Gold comprises 3.1 million active participants mostly from GP practices in Wales and Scotland.'

selected: for the UK - '1 618 395 from CPRD Gold; 5 729 800 from CPRD Aurum;'

Aurum base was 13 million of which only 5.7 selected while Gold base was 3.1 million and only 1.6 selected. Why not all of them from each base?

k 

4. 'Data may be obtained from a third party and are not publicly available. CPRD: CPRD data were obtained under the CPRD multi-study license held by the University of Oxford after Research Data Governance (RDG) approval. Direct data sharing is not allowed. SIDIAP: In accordance with current European and national law, the data used in this study is only available for the researchers participating in this study. Thus, we are not allowed to distribute or make publicly available the data to other parties.'

---

data